Regional Account Manager-Neurology (Upper Mid West based Candidates)
Axsome Therapeutics IncSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries
Requirements
Candidates are required to possess a Bachelor’s degree and at least 5 years of experience in biotech/pharma sales, with preference for experience in cardiology, rare diseases, or specialty products. Experience with sole territory ownership is highly preferred, and experience with specialty product launches is also desired.
Responsibilities
As a Cardiovascular Account Specialist, you will introduce Cytokinetics in your dedicated territory and launch its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM). This includes developing territory-specific account plans, identifying and developing business relationships with strategic IDNs and Hospitals, cardiology clinics, and specialty pharmacies, and serving as a subject matter expert and resource to customers by delivering clinically relevant disease and product information. You will also be responsible for communicating approved resources to HCPs and focusing on creating demand for the product launch.
Skills
Biotech/Pharma Sales
Cardiology
Rare Disease
Specialty Product Launch
Account Planning
Customer Engagement
Territory Management
Cytokinetics
Develops drugs for muscle function disorders
About Cytokinetics
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.
Key Metrics
South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees